Dystrophic Epidermolysis Bullosa Latest Advances
Find the Latest Research About Dystrophic Epidermolysis Bullosa
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1721 publications
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib.
Journal: Journal of drugs in dermatology : JDD
Published: April 03, 2026
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
Journal: Journal of cutaneous medicine and surgery
Published: March 25, 2026
A Novel Nasal Continuous Positive Airway Pressure-Assisted Approach for Airway Management in a Patient With Dystrophic Epidermolysis Bullosa: A Case Report.
Journal: Cureus
Published: March 14, 2026
An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa.
Journal: Expert opinion on biological therapy
Published: March 01, 2026
Base-edited skin equivalents: A promising ex vivo approach for recessive dystrophic epidermolysis bullosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 15, 2026
Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy.
Journal: Journal of drugs in dermatology : JDD
Published: February 05, 2026
Genotype-Phenotype Correlations in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review.
Journal: JAMA dermatology
Published: February 04, 2026
Bullous Diseases in the Perioperative Setting: Anesthetic Considerations.
Journal: Cureus
Published: January 13, 2026
Case Report: Two neonatal cases of genetically confirmed junctional epidermolysis bullosa in a tertiary care center.
Journal: Frontiers in pediatrics
Published: January 11, 2026
O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial.
Journal: The British journal of dermatology
Published: December 18, 2025
The Role of Biodegradable Temporizing Matrix in Hand Surgery for Paediatric Recessive Dystrophic Epidermolysis Bullosa.
Journal: Journal of clinical medicine
Published: December 13, 2025
Perioperative pressure ulcer prevention and skin protection strategies in a patient with epidermolysis bullosa undergoing long-duration surgery.
Journal: Journal of dental anesthesia and pain medicine
Published: December 11, 2025
Last Updated: 04/28/2026